The active immunisation of healthy cats against feline viral rhinotracheitis, feline calici virus and feline panleucopenia viral infections.

Storage Instructions:

• The vaccine must be stored in the dark between 2 °C and 8 °C.
• Avoid prolonged or repetitive exposure to high ambient temperatures following withdrawal from the refrigerator prior to use. Under hot summer conditions vaccine potency can be severely reduced within a few hours.
• The Nobivac Solvent may be stored at room temperature (between 20 °C and 25 °C).
• Protect from direct sunlight.
• Composition: This is a combined, live attenuated strain of feline viral rhinotracheitis, feline calicivirus and feline panleucopenia viruses grown in cell-line tissue culture and presented as a freeze-dried plug. Each vial contains a single dose for reconstitution with solvent.

Contents:
Each 1,0 ml vial of lyophilised substance contains not less than 10^4,5 pfu viral rhinotracheitis (FVR) strain G2620, not less than 10^4,5 pfu feline calicivirus (FVC) strain F9 and not less than 10^4,5 TCID ₅₀ of feline panleucopenia virus (FPL) with 58,05 mg hydrolysed gelatin, 58,05 mg sucrose and 1,04 mg disodium hydrogen phosphate.

Nobivac Solvent Contains per 1 ml :

• Disodium hydrogen phosphate 0,681 mg
• Potassium dihydrogen phosphate 0,170 mg
• Water for injection to 1 ml

Warnings:

• Do not freeze.
• Following vaccination, contact with potential sources of respiratory infection should be avoided until 7 days after the second inoculation. Protection against feline panleucopenia viral infection (feline infection enteritis) is gained more rapidly and is usually established 7 days after inoculation.
• Vaccination during pregnancy is inadvisable.
• Accidental self-injection may lead to severe local allergic reaction. Consult a physician.
• Destroy any unused vaccine, by for example, burning and dispose of all vaccination containers after vaccination.
• Do not store partially used containers for future use, and use the entire contents when opened.
• Do not mix with other vaccines.
• Keep out of reach of children and uninformed persons.
• Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, notify the registration holder.

Precautions:

• Vaccinate healthy cats only.
• Observe aseptic precautions. Ensure that the vaccination equipment (needles, syringes, etc) are clean and sterile prior to use.
• Avoid contamination of the vaccine with traces of disinfect or spirit.
• Dissolve the freeze-dried plug in Nobivac Solvent. Allow to reach room temperature before use.
• Ensure that the freeze-dried plug is completely dissolved in Nobivac Solvent prior to use of the vaccine.
• Avoid intravenous injection.
• It is good vaccination practice when handling the vaccine to avoid contact with the eyes, hands and clothing.

Directions for Use:

• Use only as directed.
• The contents of one vial of reconstituted vaccine should be injected subcutaneously or intramuscularly.
• Reconstitute immediately prior to use by the addition of one vial of Nobivac Solvent.

Initial vaccination:

• The preferred age of initial vaccination of kittens:
• • 1st dose at 12 weeks of age
  • 2nd dose at 15 - 16 weeks of age.

Re-vaccination:

•  dose annually.
• Where earlier protection is desirable (or necessary):
• • First vaccination: 1st dose at 9 weeks of age
  • 2nd dose at 12 weeks of age.

Re-vaccination:

• 1 dose annually.
• Only healthy cats should be vaccinated and an adequate clinical examination should be made prior to inoculation.

Presentation:
5 x single dose vials with 5 vials Nobivac Solvent per cardboard box.

Registration holder 
Intervet S.A. (Pty) Ltd
Co. Reg. No. 1991/006580/07